A

Aptamer Group

51 employees

Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Targeted delivery
Custom reagents
Agriculture testing
Biomarker discovery
Affinity ligands
ADCs / AOCs
Assay Development
Health Diagnostics
Health Care
Aptamers
Research and Development
Environmental testing
Drug development
Custom development
Affinity chromatography ligands
Diagnostic tools
QC reagents

Date founded

2008

Funding rounds raised

Total raised

$2.2M

from 1 investors over 1 rounds

A

Aptamer Group raised $2.2M on June 29, 2018

Investors: Meneldor

FAQ